Skip to content

Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study

Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02061579
Acronym
IMPACT
Enrollment
354
Registered
2014-02-13
Start date
2016-10-31
Completion date
2020-01-31
Last updated
2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Physical Activity

Brief summary

The Initiate and Maintain Physical Activity in Clinics (IMPACT) study will determine the optimal and feasible level of frequency of structured contact needed in a clinical setting for adult patients with Type 2 Diabetes Mellitus to initiate and maintain physical activity recommendations long-term.

Detailed description

The IMPACT Study will compare the health outcomes and lifestyle habits amongst the three groups of study participants. Study participants will be randomized into three exercise group. Group 1 will participate in instructor-led exercise training sessions 1 time per week, for 24 weeks (approximately 6 months). Group 2 will participate in instructor-led exercise training sessions 3 times per week, for 24 weeks (approximately 6 months). Group 3 will not attend any instructor-led exercise training sessions. All groups will be encouraged to see their usual providers for routine healthcare, and continue their usual medication regimen.

Interventions

BEHAVIORALStructured Group Exercise

The study intervention is a 6-month exercise program with structured group sessions conducted in a clinical setting. Group sessions include Aerobic Training and Combined Training. Once-Weekly participants will attend one Combined Training session while thrice-weekly participants will attend two Combined Training sessions and one Aerobic Training session per week. Participants in both groups will attend three exercise evaluations during the intervention period. Participants will also use provided logs to track their daily exercise activities outside of group sessions. Physical activity will be assessed by group session attendance, exercise resistance and intensity, and exercise frequency data collected from exercise logs, surveys, and evaluations.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Recent hemoglobin A1c result between 6.5 and 13.0% * Diagnosed with Type 2 Diabetes Mellitus * Able and willing to enroll and meet the requirements of the study

Exclusion criteria

* Inability to speak, read or understand English * Long-term current use or dependency on insulin * Systolic blood pressure \>180 mm Hg or diastolic blood pressure \>100 mm Hg * Resting heart rate \> 120 bpm * History of or present heart or cardiovascular conditions * History of or present respiratory disease * History of or present spinal cord injury * History of stroke or Transient Ischemic Attack (TIA) * History of cancer diagnosis in the past 5 years or present cancer diagnosis * Medical, psychiatric, behavioral limitations that may interfere with study participation * Participating in other clinical trials that may interfere with study procedures and outcomes * Currently pregnant or plans to become pregnant within three years

Design outcomes

Primary

MeasureTime frame
Changes in Hemoglobin A1c Level Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Maximal Oxygen Consumption Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Self-Reported Physical Activity Level Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up

Secondary

MeasureTime frame
Changes in Blood Pressure Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Heart Rate Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Dietary Intake Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Body Weight Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Exercise Perception Across Study VisitsBaseline, 6-, 30-month follow-up
Changes in Patient Satisfaction During Intervention Period3-, 6-month follow-up
Changes in Self-Reported Quality of Life Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Body Mass Index Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up
Changes in Waist Circumference Across Study VisitsBaseline, 3-, 6-, 18-, 24-, 30-month follow-up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026